BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18384840)

  • 1. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
    Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patricio B; Quintanilha A; Santos-Silva A
    Thromb Res; 2008; 123(2):219-24. PubMed ID: 18384840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemostatic factors in women with history of preeclampsia.
    Portelinha A; Cerdeira AS; Belo L; Braga J; Tejera E; Pinto A; Pinto F; Areias MJ; Patrício B; Rebelo I
    Thromb Res; 2009 May; 124(1):52-6. PubMed ID: 19049844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte changes in preeclampsia: relationship between maternal and cord blood erythrocyte damage.
    Catarino C; Rebelo I; Belo L; Rocha-Pereira P; Rocha S; Bayer Castro E; Patrício B; Quintanilha A; Santos-Silva A
    J Perinat Med; 2009; 37(1):19-27. PubMed ID: 18783307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia.
    Braekke K; Holthe MR; Harsem NK; Fagerhol MK; Staff AC
    Am J Obstet Gynecol; 2005 Jul; 193(1):227-33. PubMed ID: 16021084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe preeclampsia: are hemostatic and inflammatory parameters associated?
    Pinheiro MB; Carvalho MG; Martins-Filho OA; Freitas LG; Godoi LC; Alpoim PN; Gomes KB; Dusse LM
    Clin Chim Acta; 2014 Jan; 427():65-70. PubMed ID: 24121033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy.
    Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patrício B; Quintanilha A; Santos-Silva A
    Growth Factors; 2009 Dec; 27(6):345-51. PubMed ID: 19919522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurokinin B levels in maternal and umbilical cord blood in preeclamptic and normal pregnancies.
    Zulfikaroglu E; Ugur M; Taflan S; Ugurlu N; Atalay A; Kalyoncu S
    J Perinat Med; 2007; 35(3):200-2. PubMed ID: 17480147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
    Pradhan AD; LaCroix AZ; Langer RD; Trevisan M; Lewis CE; Hsia JA; Oberman A; Kotchen JM; Ridker PM
    Circulation; 2004 Jul; 110(3):292-300. PubMed ID: 15238458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal lipoprotein changes in pre-eclampsia.
    Catarino C; Rebelo I; Belo L; Rocha-Pereira P; Rocha S; Castro EB; Patrício B; Quintanilha A; Santos-Silva A
    Acta Obstet Gynecol Scand; 2008; 87(6):628-34. PubMed ID: 18568462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.
    Coolman M; de Groot CJ; Steegers EA; Geurts-Moespot A; Thomas CM; Steegers-Theunissen RP; Sweep FC
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):22-8. PubMed ID: 16584829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia.
    Schjetlein R; Abdelnoor M; Haugen G; Husby H; Sandset PM; Wisløff F
    Acta Obstet Gynecol Scand; 1999 Mar; 78(3):191-7. PubMed ID: 10078579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipocytokines and endothelial function in preeclamptic women.
    Mori T; Shinohara K; Wakatsuki A; Watanabe K; Fujimaki A
    Hypertens Res; 2010 Mar; 33(3):250-4. PubMed ID: 20075929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy.
    Choi JW; Pai SH
    Ann Hematol; 2002 Nov; 81(11):611-5. PubMed ID: 12454697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of the hemostasis parameters in the development of preeclampsia.
    Ho CH; Yang ZL
    Thromb Haemost; 1992 Feb; 67(2):214-8. PubMed ID: 1621241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    Gynecol Obstet Invest; 2007; 64(1):8-13. PubMed ID: 17199090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal and maternal serum levels of soluble ICAM-1 in preeclamptic and normal pregnancies.
    Aliefendioğlu D; Erdem G; Tülek N; Yurdakök M
    Am J Perinatol; 2002 Aug; 19(6):333-9. PubMed ID: 12357425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia.
    Gilabert J; Estellés A; Aznar J; España F; Andrés C; Santos T; Vallés J
    Thromb Haemost; 1990 Jun; 63(3):361-6. PubMed ID: 2144918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating calcitonin gene-related peptide and its placental origins in normotensive and preeclamptic pregnancies.
    Dong YL; Chauhan M; Green KE; Vegiraju S; Wang HQ; Hankins GD; Yallampalli C
    Am J Obstet Gynecol; 2006 Dec; 195(6):1657-67. PubMed ID: 16996466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.